
About


Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope

Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies

EU Pharma Legislation Review Series: Decentralized Manufacturing

EU Pharma Legislation Review Series: Supply Security and Shortages Control

EU Pharma Legislation Review Series: GMO Medicines

EU Pharma Legislation Review Series: Addressing Environmental Risks

EU Pharma Legislation Review Series: AMR and Transferable Exclusivity Vouchers
